 3. less than 28 days from prior cytotoxic therapy except 23 days from prior temozolomide, 14 days from vincristine for GBM: 14 days from irinotecan or topotecan, 42 days from nitrosoureas, 21 days from procarbazine, irinotecan or topotecan administration; 